296 related articles for article (PubMed ID: 23373317)
1. [Restorative therapy in amyotrophic lateral sclerosis].
Aoki M
Nihon Shinkei Seishin Yakurigaku Zasshi; 2012 Nov; 32(5-6):287-92. PubMed ID: 23373317
[TBL] [Abstract][Full Text] [Related]
2. [Hepatocyte growth factor therapy for amyotrophic lateral sclerosis].
Aoki M
Brain Nerve; 2012 Mar; 64(3):245-54. PubMed ID: 22402718
[TBL] [Abstract][Full Text] [Related]
3. [Development of motor neuron restorative therapy in amyotrophic lateral sclerosis using hepatocyte growth factor].
Aoki M; Warita H; Suzuki N; Itoyama Y
Rinsho Shinkeigaku; 2009 Nov; 49(11):814-7. PubMed ID: 20030218
[TBL] [Abstract][Full Text] [Related]
4. [Regenerative therapies for amyotrophic lateral sclerosis using hepatocyte growth factor].
Aoki M; Warita H; Suzuki N; Kato M; Itoyama Y
Rinsho Shinkeigaku; 2011 Nov; 51(11):1195-8. PubMed ID: 22277532
[TBL] [Abstract][Full Text] [Related]
5. Intrathecal delivery of hepatocyte growth factor from amyotrophic lateral sclerosis onset suppresses disease progression in rat amyotrophic lateral sclerosis model.
Ishigaki A; Aoki M; Nagai M; Warita H; Kato S; Kato M; Nakamura T; Funakoshi H; Itoyama Y
J Neuropathol Exp Neurol; 2007 Nov; 66(11):1037-44. PubMed ID: 17984685
[TBL] [Abstract][Full Text] [Related]
6. [Application of Hepatocyte Growth Factor for Amyotrophic Lateral Sclerosis].
Aoki M; Warita H; Kato M; Suzuki N
Brain Nerve; 2019 Nov; 71(11):1253-1260. PubMed ID: 31722311
[TBL] [Abstract][Full Text] [Related]
7. [Amyotrophic lateral sclerosis with the SOD1 mutations].
Aoki M; Warita H; Itoyama Y
Rinsho Shinkeigaku; 2008 Nov; 48(11):966-9. PubMed ID: 19198133
[TBL] [Abstract][Full Text] [Related]
8. [Clinical translation of hepatocyte growth factor for amyotrophic lateral sclerosis].
Warita H; Kato M; Suzuki N; Itoyama Y; Aoki M
Rinsho Shinkeigaku; 2012; 52(11):1214-7. PubMed ID: 23196568
[TBL] [Abstract][Full Text] [Related]
9. [Amyotrophic lateral sclerosis: recent insights from transgenic animal models with SOD1 mutations].
Aoki M
Rinsho Shinkeigaku; 2004 Nov; 44(11):788-91. PubMed ID: 15651292
[TBL] [Abstract][Full Text] [Related]
10. Rats expressing human cytosolic copper-zinc superoxide dismutase transgenes with amyotrophic lateral sclerosis: associated mutations develop motor neuron disease.
Nagai M; Aoki M; Miyoshi I; Kato M; Pasinelli P; Kasai N; Brown RH; Itoyama Y
J Neurosci; 2001 Dec; 21(23):9246-54. PubMed ID: 11717358
[TBL] [Abstract][Full Text] [Related]
11. Development of a rat model of amyotrophic lateral sclerosis expressing a human SOD1 transgene.
Aoki M; Kato S; Nagai M; Itoyama Y
Neuropathology; 2005 Dec; 25(4):365-70. PubMed ID: 16382787
[TBL] [Abstract][Full Text] [Related]
12. Motor neuron dysfunction in a mouse model of ALS: gender-dependent effect of P2X7 antagonism.
Cervetto C; Frattaroli D; Maura G; Marcoli M
Toxicology; 2013 Sep; 311(1-2):69-77. PubMed ID: 23583883
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic benefits of intrathecal protein therapy in a mouse model of amyotrophic lateral sclerosis.
Ohta Y; Kamiya T; Nagai M; Nagata T; Morimoto N; Miyazaki K; Murakami T; Kurata T; Takehisa Y; Ikeda Y; Asoh S; Ohta S; Abe K
J Neurosci Res; 2008 Oct; 86(13):3028-37. PubMed ID: 18543336
[TBL] [Abstract][Full Text] [Related]
14. Intrathecal transplantation of human neural stem cells overexpressing VEGF provide behavioral improvement, disease onset delay and survival extension in transgenic ALS mice.
Hwang DH; Lee HJ; Park IH; Seok JI; Kim BG; Joo IS; Kim SU
Gene Ther; 2009 Oct; 16(10):1234-44. PubMed ID: 19626053
[TBL] [Abstract][Full Text] [Related]
15. Oxidative stress, mutant SOD1, and neurofilament pathology in transgenic mouse models of human motor neuron disease.
Tu PH; Gurney ME; Julien JP; Lee VM; Trojanowski JQ
Lab Invest; 1997 Apr; 76(4):441-56. PubMed ID: 9111507
[TBL] [Abstract][Full Text] [Related]
16. A dopamine receptor antagonist L-745,870 suppresses microglia activation in spinal cord and mitigates the progression in ALS model mice.
Tanaka K; Okada Y; Kanno T; Otomo A; Yanagisawa Y; Shouguchi-Miyata J; Suga E; Kohiki E; Onoe K; Osuga H; Aoki M; Hadano S; Itoyama Y; Ikeda JE
Exp Neurol; 2008 Jun; 211(2):378-86. PubMed ID: 18423451
[TBL] [Abstract][Full Text] [Related]
17. Intraspinal cord delivery of IGF-I mediated by adeno-associated virus 2 is neuroprotective in a rat model of familial ALS.
Franz CK; Federici T; Yang J; Backus C; Oh SS; Teng Q; Carlton E; Bishop KM; Gasmi M; Bartus RT; Feldman EL; Boulis NM
Neurobiol Dis; 2009 Mar; 33(3):473-81. PubMed ID: 19135533
[TBL] [Abstract][Full Text] [Related]
18. Neural stem cells LewisX+ CXCR4+ modify disease progression in an amyotrophic lateral sclerosis model.
Corti S; Locatelli F; Papadimitriou D; Del Bo R; Nizzardo M; Nardini M; Donadoni C; Salani S; Fortunato F; Strazzer S; Bresolin N; Comi GP
Brain; 2007 May; 130(Pt 5):1289-305. PubMed ID: 17439986
[TBL] [Abstract][Full Text] [Related]
19. Intraspinal cell transplantation for targeting cervical ventral horn in amyotrophic lateral sclerosis and traumatic spinal cord injury.
Lepore AC
J Vis Exp; 2011 Sep; (55):. PubMed ID: 21946609
[TBL] [Abstract][Full Text] [Related]
20. Intrathecal delivery of recombinant AAV1 encoding hepatocyte growth factor improves motor functions and protects neuromuscular system in the nerve crush and SOD1-G93A transgenic mouse models.
Lee SH; Kim S; Lee N; Lee J; Yu SS; Kim JH; Kim S
Acta Neuropathol Commun; 2019 Jun; 7(1):96. PubMed ID: 31189468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]